Thursday, April 30, 2020

High cost of cancer drugs not always justified

Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clinical benefit of drugs to be better reflected in pricing.

from Top Health News -- ScienceDaily https://ift.tt/2xmmBS3
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Powerful cholesterol drug cuts heart attack risk by 31%

A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically use...